Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | DUT | P33316 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21251495 | 0.84 | TGFBR1 (0.34) | POLBEPHX1TGFBR1 | |
| SCHEMBL22768268 | 0.83 | TGFBR1 (0.32) | POLBTGFBR1 | |
| SCHEMBL19425988 | 0.82 | POLB (0.46) | POLBEPHX1HTTMAPTALDH1A1 | |
| SCHEMBL13435149 | 0.82 | TGFBR1 (0.32) | TGFBR1 | |
| SCHEMBL7611640 | 0.80 | TGFBR1 (0.39) | POLBTGFBR1ALDH1A1 | |
| SCHEMBL21612680 | 0.80 | TGFBR1 (0.35) | TGFBR1ALDH1A1 | |
| SCHEMBL9805999 | 0.80 | EPHX1 (0.40) | POLBEPHX1TGFBR1MAPTALDH1A1 | |
| SCHEMBL491400 | 0.78 | TDP1 (0.35) | TGFBR1ALDH1A1 | |
| SCHEMBL730664 | 0.78 | TGFBR1 (0.34) | TGFBR1ALDH1A1 | |
| SCHEMBL9408888 | 0.77 | POLB (0.50) | POLBEPHX1HTTMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 497 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118344520-A | Resin and preparation method and application thereof | 燧伦科技(上海)有限责任公司 | 2024-07-16 | — | — | CN | claimed |
| US-20180333345-A1 | NON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2018-11-22 | — | — | US | claimed |
| EP-3377547-A1 | ON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF | ISP Investments LLC (US) | 2018-09-26 | — | — | EP | claimed |
| EP-1378531-B1 | Reactive hot-melt adhesive compositions with improved green strength | ROHM & HAAS (US) | 2011-01-19 | — | — | EP | claimed |
| EP-0556001-B1 | Improvements in or relating to printing plates | AGFA GEVAERT NV (BE) | 1999-10-20 | — | — | EP | claimed |
| US-5698627-A | AN AQUEOUS SOLUTION OF A COPOLYMER OF AN ACRYLAMIDE, A VINYL COMPOUND HAVING A CATIONIC GROUP AND ANOTHER UNSATURATED COMPOUND PREPARED IN THE PRESENCE OF A POLYHYDROXY COMPOUND; FREENESS; RETENTION; HIGH STRENGTH | JAPAN PMC CORPORATION (JP) | 1997-12-16 | — | — | US | claimed |
| US-5609987-A | OLEOPHILIC TANNING SYNTHETIC RESIN | DU PONT (U.K.) LIMITED (GB) | 1997-03-11 | — | — | US | claimed |
| EP-0735186-A2 | Additive for papermaking and process for papermaking | JAPAN PMC CORPORATION (JP) | 1996-10-02 | — | — | EP | claimed |
| EP-0556001-A1 | Improvements in or relating to printing plates | Du Pont (UK) Limited (GB) | 1993-08-18 | — | — | EP | claimed |
| US-12365815-B2 | Polishing liquid, polishing liquid set, polishing method, and defect suppression method | RESONAC CORPORATION (JP) | 2025-07-22 | — | — | US | disclosed |
| US-20250197548-A1 | BIODEGRADABLE GRAFT POLYMERS | BASF SE (DE) | 2025-06-19 | — | — | US | disclosed |
| WO-2025111424-A1 | PARTICULATE VINYLAMINE COMPOSITIONS AND METHOD OF MAKING | SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) | 2025-05-30 | — | — | WO | disclosed |
| WO-2025111425-A1 | A METHOD OF PRODUCING VINYLAMINE-CONTAINING POLYMERS | SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) | 2025-05-30 | — | — | WO | disclosed |
| WO-2025111428-A1 | METHOD FOR PRODUCTION OF VINYL CARBOXAMIDE CONTAINING POLYMERS IN PARTICULATE FORM | SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) | 2025-05-30 | — | — | WO | disclosed |
| US-4889797-A | CONTAINING HYDROPHILIC POLYMER TO DECEASE SPREADING | FUJI PHOTO FILM CO., LTD. (JP) | 1989-12-26 | — | — | US | disclosed |
| EP-0227741-A4 | MULTICOLOR IMAGES USING AN ELECTRON BEAM. | GAF CORP (US) | 1987-11-23 | — | — | EP | disclosed |
| EP-0227741-A1 | MULTICOLOR IMAGES USING AN ELECTRON BEAM | GAF CORPORATION (US) | 1987-07-08 | — | — | EP | disclosed |
| US-4668598-A | Multicolor images using an electron beam | GAF CORPORATION (US) | 1987-05-26 | — | — | US | disclosed |
| WO-1987000645-A1 | MULTICOLOR IMAGES USING AN ELECTRON BEAM | GAF CORPORATION (US) | 1987-01-29 | — | — | WO | disclosed |
| US-4120725-A | POLYMERS OF ACRYLIC AMIDES AND OF VINYL OR ALLYL ALCOHOLS, VINYL IMIDES OR AMIDES OR VINYL MORPHOLINE | FUJI PHOTO FILM CO., LTD. (JP) | 1978-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250197548-A1 | BIODEGRADABLE GRAFT POLYMERS | PCNA, ALOX12, FASN | POLB 525/4885EPHX1 758/4885TGFBR1 1820/4885 |
| US-20180333345-A1 | NON-AQUEOUS COMPOSITIONS OF POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL MOIETY AND LACTAM MOIETY AND APPLICATIONS THEREOF | C9, C5, C1S | POLB 524/4885EPHX1 4471/4885TGFBR1 1413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.